-
公开(公告)号:US20120303112A1
公开(公告)日:2012-11-29
申请号:US13298060
申请日:2011-11-16
申请人: Joseph R. Armstrong , Edward H. Cully , Michael W. Franklin , Mark Y. Hansen , Brandon A. Lurie , Craig r. McMurray , William D. Montgomery , Wendy J. Terry , Eric M. Tittelbaugh
发明人: Joseph R. Armstrong , Edward H. Cully , Michael W. Franklin , Mark Y. Hansen , Brandon A. Lurie , Craig r. McMurray , William D. Montgomery , Wendy J. Terry , Eric M. Tittelbaugh
IPC分类号: A61F2/82
CPC分类号: A61F2/88 , A61F2/07 , A61F2/915 , A61F2/966 , A61F2002/075 , A61F2002/91558 , A61F2002/91575 , A61F2002/9583 , A61F2220/005 , A61F2220/0075 , A61F2230/0054
摘要: The invention relates to a medical device and a method of using it. The device is a stent which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The stent is configured to have a central portion defined by “open” cells and at least two end portions, defined by “closed” cells, spaced apart and directly connected to the distal and proximal ends of the central portion of the stent. The stent may also optionally have a covering or a lattice with openings.
摘要翻译: 本发明涉及医疗装置及其使用方法。 该装置是可以通过(或在)血管内导管或经由其它手术或其它技术经皮递送的支架,然后扩张。 支架被构造成具有由开放细胞限定的中心部分和由闭孔限定的至少两个端部,间隔开并且直接连接到支架的中心部分的远端和近端。 支架也可任选地具有带开口的覆盖物或格子。
-
公开(公告)号:US09839540B2
公开(公告)日:2017-12-12
申请号:US13298060
申请日:2011-11-16
申请人: Joseph R. Armstrong , Edward H. Cully , Michael W. Franklin , Mark Y. Hansen , Brandon A. Lurie , Craig R. McMurray , William D. Montgomery , Wendy J. Terry , Eric M. Tittelbaugh
发明人: Joseph R. Armstrong , Edward H. Cully , Michael W. Franklin , Mark Y. Hansen , Brandon A. Lurie , Craig R. McMurray , William D. Montgomery , Wendy J. Terry , Eric M. Tittelbaugh
CPC分类号: A61F2/88 , A61F2/07 , A61F2/915 , A61F2/966 , A61F2002/075 , A61F2002/91558 , A61F2002/91575 , A61F2002/9583 , A61F2220/005 , A61F2220/0075 , A61F2230/0054
摘要: The invention relates to a medical device and a method of using it. The device is a stent which can be percutaneously deliverable with (or on) an endovascular catheter or via other surgical or other techniques and then expanded. The stent is configured to have a central portion defined by “open” cells and at least two end portions, defined by “closed” cells, spaced apart and directly connected to the distal and proximal ends of the central portion of the stent. The stent may also optionally have a covering or a lattice with openings.
-